Abstract
In this issue of Blood, Al Sayed et al demonstrate a critical role for CD70 signaling in natural killer (NK)–cell elimination of lymphoma, providing the pre-clinical groundwork for a new coactivating NK-cell immunotherapy strategy.1
| Original language | English |
|---|---|
| Pages (from-to) | 238-239 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 130 |
| Issue number | 3 |
| DOIs |
|
| State | Published - Jul 20 2017 |